Salbutamol oral - Recordati

Drug Profile

Salbutamol oral - Recordati

Alternative Names: Albuterol CRSS; Albuterol oral - Ascent Pediatrics; Albuterol oral - Recordati; Salbutamol CRSS; Salbutamol oral - Ascent Pediatrics; SCH 13949W oral - Ascent Pediatrics; SCH 13949W oral - Recordati

Latest Information Update: 07 Feb 2001

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Recordati
  • Developer Medicis Pediatrics
  • Class Antiasthmatics; Antibronchitics; Bronchodilators; Ethanolamines; Phenethylamines; Small molecules; Tocolytics
  • Mechanism of Action Beta 2 adrenergic receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Asthma

Most Recent Events

  • 07 Feb 2001 Discontinued-III for Asthma in USA (PO)
  • 27 Sep 1999 Phase III trials in asthma completed in the US
  • 06 Nov 1998 New profile
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top